Publication:

Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism

Loading...
Thumbnail Image

Date

2016

Journal Title

Journal ISSN

Volume Title

Publisher

Springer US
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Vedantham, Suresh, Gregory Piazza, Akhilesh K. Sista, and Neil A. Goldenberg. 2016. “Guidance for the use of thrombolytic therapy for the treatment of venous thromboembolism.” Journal of Thrombosis and Thrombolysis 41 (1): 68-80. doi:10.1007/s11239-015-1318-z. http://dx.doi.org/10.1007/s11239-015-1318-z.

Abstract

Patients with venous thromboembolism (VTE) are prone to the development of both short-term and long-term complications that can substantially affect their functional capacity and quality of life. Patients with deep vein thrombosis (DVT) often develop recurrent VTE or the post-thrombotic syndrome, whereas patients with pulmonary embolism (PE) can develop long-term symptoms and functional limitations along a broad spectrum extending to full-blown chronic thromboembolic pulmonary hypertension. Clinicians who care for patients showing severe clinical manifestations of DVT and PE are often faced with challenging decisions concerning whether and how to escalate to more aggressive treatments such as those involving the use of thrombolytic drugs. The purpose of this chapter is to provide guidance on how best to individualize care to these patients.

Description

Research Data

Keywords

Venous thromboembolism, Pulmonary embolism, Thrombolytic therapy, Anticoagulants, Direct oral anticoagulants (DOAC), New oral anticoagulants (NOAC)

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories